🇺🇸 FDA
Pipeline program

Calcichew D3

Calcichew-4001

Approved small_molecule completed

Quick answer

Calcichew D3 for Calcium and Vitamin D Deficiencies is a Approved program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).

Program details

Company
Takeda Pharmaceuticals International AG
Indication
Calcium and Vitamin D Deficiencies
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials